| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 08/05/2004 | US20040152892 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 08/05/2004 | US20040152889 Process for the preparation of benazepril |
| 08/05/2004 | US20040152888 novel benzodiazepine derivatives |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152718 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds |
| 08/05/2004 | US20040152717 Urogenital disorders; bleeding; hormone replacement therapy; anticancer agents; contraceptives |
| 08/05/2004 | US20040152707 Analgesics; anxiolytic agents; antihistamines; antitussive agents; antidepressants; alcoholism |
| 08/05/2004 | US20040152697 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 08/05/2004 | US20040152693 For therapy of conditions associated with muscle spasms, epilepsy, acute and chronic forms of neurodegenerative diseases; for therapy andprophylaxis of acute and chronic inflammatory disorders |
| 08/05/2004 | US20040152672 Indole compounds useful for the treatment of cancer |
| 08/05/2004 | US20040149022 Noise detection system and method |
| 08/05/2004 | CA2513501A1 2.4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 08/05/2004 | CA2511491A1 Androgen receptor antagonists |
| 08/05/2004 | CA2511089A1 Androgen receptor antagonists |
| 08/04/2004 | EP1443049A1 Process for the preparation of ketals |
| 08/04/2004 | EP1442037A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1441734A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441721A2 Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 08/04/2004 | CN1160069C Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 08/03/2004 | US6770654 Indole derivatives and use thereof in medicines |
| 08/03/2004 | US6770652 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 08/03/2004 | US6770646 Substituted fused pyridazinone compounds; composition and use thereof |
| 08/03/2004 | US6770641 Fused heteroaryl derivatives |
| 08/03/2004 | US6770639 Cell proliferative; autoimmune diseases; antiallergens; antiinflammatory agents; anticancer agents |
| 07/29/2004 | WO2004063202A1 Fused furan compound |
| 07/29/2004 | WO2004063201A1 Therapeutic agent for schizophrenia |
| 07/29/2004 | WO2004063169A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | WO2004062629A2 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells |
| 07/29/2004 | WO2004062590A2 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| 07/29/2004 | WO2004050629A3 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
| 07/29/2004 | US20040147747 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147580 Therapy for bacteria infections |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147561 Pyrid-2-one derivatives and methods of use |
| 07/29/2004 | US20040147530 Urogenital disorders; dysmenorrhea; endometriosis; anticancer agents |
| 07/29/2004 | US20040147523 Premenstrual syndrome; anxiolytic agents; attention deficit disorders; obsessive compulsive disorders; eating disorders; alcoholism; sexual disorders |
| 07/29/2004 | US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation |
| 07/29/2004 | US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 07/29/2004 | DE10301804A1 New 6-alkyl-2,4-dihalophenyl-substituted tetramic acid derivatives, useful as herbicides and pesticides, especially insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents |
| 07/29/2004 | CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | CA2512765A1 Therapeutic agent for schizophrenia |
| 07/28/2004 | EP1440075A1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof |
| 07/28/2004 | EP1440066A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1140862A4 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/28/2004 | EP1001761B1 Use of cholinesterase inhibitors for treating attention deficit disorders |
| 07/28/2004 | EP0931065B1 use of NITRIC ESTER DERIVATIVES IN the treatment of URINARY INCONTINENCE |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | CN1516872A Optical data carrier that contains triazacyanine dye as light-absorbing compound in information layer |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1516583A Pharmaceutical compositions comprising chelidonine or derivatives thereof |
| 07/28/2004 | CN1515566A Substituted chromene derivative for curing inflammation |
| 07/28/2004 | CN1515551A 1,2-indane or indoline derivative |
| 07/28/2004 | CN1159318C Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/28/2004 | CN1159303C Preparation of intermediate for monocyclic beta-lactams antibiotic derivatives |
| 07/28/2004 | CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives |
| 07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
| 07/22/2004 | WO2004060890A1 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases |
| 07/22/2004 | WO2004005289B1 Efficient synthesis of pyropheophorbide a and its derivatives |
| 07/22/2004 | WO2004002406A3 Bicyclic pyrimidinones as coagulation cascade inhibitors |
| 07/22/2004 | US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/22/2004 | US20040142949 Compounds, compositions, and methods |
| 07/22/2004 | US20040142926 5HT1A antagonist; obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder |
| 07/22/2004 | US20040142922 Benzodioxole derivatives |
| 07/22/2004 | CA2509213A1 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | CN1515002A Optical data carrier whose information layer contains light-absorbing compound having a number of chromophoric centers |
| 07/21/2004 | CN1514841A Synthesis of silyl camptothecins and silyl homo camptothecins |
| 07/21/2004 | CN1514829A Novel herbicides |
| 07/21/2004 | CN1513844A New Carboxglic acid derivative, its preparation and application |
| 07/21/2004 | CN1158285C Process for large-scale preparing tetrodotoxin high-purity monomer |
| 07/21/2004 | CN1158282C Camptothecine like compound, its preparing method and medicinal composition containing them |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 07/20/2004 | US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765006 Antagonists of amino-3-hydroxy-5-methylisoxazole-4-propionic acid (ampa) ionotropic receptors; neurodegenerative, alzheimer's, and huntington's disease; amyotrophic lateral sclerosis; schizophrenia, excitatory amino acid deficiency |
| 07/15/2004 | WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 07/15/2004 | WO2004058763A1 4(spiropiperidinyl)methyl substituted pyrrolidines as modulators of chemokine receptor activity |
| 07/15/2004 | WO2004058755A2 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors |
| 07/15/2004 | WO2004058749A1 Benzisoxazole derivatives useful as inhibitors of protein kinases |
| 07/15/2004 | WO2004058727A1 Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
| 07/15/2004 | WO2004058720A2 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor |
| 07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | WO2004058265A1 Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors |
| 07/15/2004 | WO2004058264A1 Compound libraries of 2h-spiro (isoquinoline-1, -piperidine derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor |
| 07/15/2004 | WO2004058263A1 Compound libraries of 2, 3, 4, 9-tetrahydrospiro (beta-carboline-1, 4 -piperidine) derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor |
| 07/15/2004 | WO2004058259A1 Compound libraries of n-(aminocarbonyl)-piperidine-4-carboxamide derivatives capable of binding to g-protein coupled receptors |
| 07/15/2004 | WO2004058144A2 Antibacterial agents |
| 07/15/2004 | WO2004041163A3 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 07/15/2004 | WO2004037373A3 CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF β-GLUCOSIDASE |
| 07/15/2004 | WO2004032848A3 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/15/2004 | WO2004004714A1 Spirocyclic piperidines as mch1 antagonists and uses thereof |